PMID- 33270895
OWN - NLM
STAT- MEDLINE
DCOM- 20220411
LR  - 20221207
IS  - 0160-6972 (Print)
IS  - 0160-6972 (Linking)
VI  - 48
IP  - 1
DP  - 2022 Feb 1
TI  - Influence of Glycemic Control on the Survival of Implants Placed in the Zygomatic 
      Bone of Edentulous Patients With and Without Type 2 Diabetes Mellitus: 10-Year 
      Follow-Up Results.
PG  - 21-26
LID - 10.1563/aaid-joi-D-20-00261 [doi]
AB  - It is hypothesized that under optimal glycemic control (GC), there is no 
      difference in the survival of implants placed in the zygomatic bone of edentulous 
      patient with and without type 2 diabetes mellitus (T2DM). The aim was to assess 
      the influence of GC on survival of implants placed in the zygomatic bone of an 
      edentulous patient with and without T2DM at the 10-year follow-up. Twenty 
      patients with T2DM (10 with poorly controlled T2DM and 10 with well-controlled 
      T2DM) and 12 patients without T2DM were included. Hemoglobin A1c (HbA1c) levels 
      were recorded, and demographic data were collected from all participants. 
      Peri-implant inflammatory parameters (plaque index [PI], probing depth [PD], 
      crestal bone loss [BL], and gingival index [GI]) were measured in all patients. 
      Group comparisons were done, and P values, which were less than .01, were 
      indicative of statistical significance. Twenty and 12 male patients with and 
      without T2DM, respectively, were included. Among patients with T2DM, 10 and 10 
      individuals had poorly and well-controlled T2DM, respectively. The mean HbA1c 
      levels were significantly higher in patients with poorly controlled T2DM (9.2 +/- 
      0.7%) compared with well-controlled T2DM (4.8 +/- 0.3%; P < .01) and nondiabetic 
      individuals (4.6 +/- 0.3%; P < .01). The crestal BL on the mesial (P < .01) and 
      distal (P < .01) surfaces, PD (P < .01), PI (P < .01), and GI (P < .01) were 
      significantly higher around all zygoma implants placed in patients with poorly 
      controlled T2DM compared with patients with well-controlled T2DM and patients 
      without T2DM. These clinicoradiographic parameters were comparable around zygoma 
      implants placed in patient with well-controlled T2DM and in subjects without 
      T2DM. Optimal GC is essential for the long-term stability of zygomatic plants in 
      patients with T2DM.
FAU - Alresayes, Saad
AU  - Alresayes S
AD  - Department of Prosthetic Dental Science, College of Dentistry, King Saud 
      University, Riyadh, Saudi Arabia.
FAU - Al Deeb, Modhi
AU  - Al Deeb M
AD  - Department of Prosthetic Dental Science, College of Dentistry, King Saud 
      University, Riyadh, Saudi Arabia.
FAU - Al-Hamoudi, Nawwaf
AU  - Al-Hamoudi N
AD  - Department of Periodontics and Community Dentistry, College of Dentistry, King 
      Saud University, Riyadh, Saudi Arabia.
FAU - Javed, Fawad
AU  - Javed F
AD  - Department of Orthodontics, Eastman Institute for Oral Health, University of 
      Rochester, New York, USA.
FAU - Vohra, Fahim
AU  - Vohra F
AD  - Department of Prosthetic Dental Science, College of Dentistry, King Saud 
      University, Riyadh, Saudi Arabia.
FAU - Abduljabbar, Tariq
AU  - Abduljabbar T
AD  - Department of Prosthetic Dental Science, College of Dentistry, King Saud 
      University, Riyadh, Saudi Arabia.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - J Oral Implantol
JT  - The Journal of oral implantology
JID - 7801086
RN  - 0 (Dental Implants)
RN  - 0 (Glycated Hemoglobin A)
MH  - *Alveolar Bone Loss
MH  - *Dental Implants
MH  - *Diabetes Mellitus, Type 2/complications
MH  - Follow-Up Studies
MH  - Glycated Hemoglobin/analysis
MH  - Glycemic Control
MH  - Humans
MH  - Male
MH  - *Mouth, Edentulous
MH  - Zygoma/chemistry/surgery
OTO - NOTNLM
OT  - bleeding on probing
OT  - crestal bone loss
OT  - dental implants
OT  - type 2 diabetes mellitus
OT  - zygoma
EDAT- 2020/12/04 06:00
MHDA- 2022/04/12 06:00
CRDT- 2020/12/03 17:16
PHST- 2020/12/04 06:00 [pubmed]
PHST- 2022/04/12 06:00 [medline]
PHST- 2020/12/03 17:16 [entrez]
AID - 449192 [pii]
AID - 10.1563/aaid-joi-D-20-00261 [doi]
PST - ppublish
SO  - J Oral Implantol. 2022 Feb 1;48(1):21-26. doi: 10.1563/aaid-joi-D-20-00261.